A Phase 2a Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Adults With Asthma
Clinical trial NCT00783289 · COMPLETED
Trial details
- NCT number
- NCT00783289
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-14
- Primary completion
- 2009-11-17
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.